David Oldach

5.5k total citations · 2 hit papers
86 papers, 4.2k citations indexed

About

David Oldach is a scholar working on Epidemiology, Environmental Chemistry and Molecular Biology. According to data from OpenAlex, David Oldach has authored 86 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 18 papers in Environmental Chemistry and 17 papers in Molecular Biology. Recurrent topics in David Oldach's work include Marine Toxins and Detection Methods (18 papers), Hepatitis C virus research (15 papers) and Microbial Community Ecology and Physiology (13 papers). David Oldach is often cited by papers focused on Marine Toxins and Detection Methods (18 papers), Hepatitis C virus research (15 papers) and Microbial Community Ecology and Physiology (13 papers). David Oldach collaborates with scholars based in United States, France and Germany. David Oldach's co-authors include Robert Thimme, Francis V. Chisari, Kyong‐Mi Chang, Stuart C. Ray, Torstein Tengs, Holly A. Bowers, Diane K. Stoecker, JoAnn M. Burkholder, Parke A. Rublee and Matthew D. Johnson and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

David Oldach

86 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

2001 933 citations David Oldach et al. profile →
Neutralizing antibody response during acute and chronic hepatitis C virus infection

2004 332 citations Carine Logvinoff, Marian Major et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Oldach United States	29	1.8k	1.7k	806	769	765	86	4.2k
Brian Foley United States	34	663 0.4×	213 0.1×	1.2k 1.4×	121 0.2×	265 0.3×	126	4.8k
Enid Shephard South Africa	25	589 0.3×	121 0.1×	679 0.8×	106 0.1×	77 0.1×	77	2.1k
Matthew R. Henn United States	35	534 0.3×	118 0.1×	1.6k 2.0×	106 0.1×	1.3k 1.7×	81	4.2k
Salvador Benlloch Spain	22	758 0.4×	686 0.4×	450 0.6×	60 0.1×	333 0.4×	71	2.0k
Tetsuo Hashimoto Japan	38	386 0.2×	114 0.1×	2.0k 2.5×	187 0.2×	929 1.2×	174	4.2k
Christine M. Durand United States	37	2.0k 1.1×	916 0.5×	464 0.6×	263 0.3×	162 0.2×	135	5.6k
J. Moreau France	19	415 0.2×	181 0.1×	322 0.4×	61 0.1×	265 0.3×	54	1.8k
Paola Fisicaro France	28	2.0k 1.1×	1.6k 0.9×	328 0.4×	50 0.1×	30 0.0×	104	3.8k
Maria Andersson Sweden	31	403 0.2×	183 0.1×	336 0.4×	232 0.3×	382 0.5×	88	2.6k

Countries citing papers authored by David Oldach

Since Specialization

Citations

This map shows the geographic impact of David Oldach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Oldach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Oldach more than expected).

Fields of papers citing papers by David Oldach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Oldach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Oldach. The network helps show where David Oldach may publish in the future.

Co-authorship network of co-authors of David Oldach

This figure shows the co-authorship network connecting the top 25 collaborators of David Oldach. A scholar is included among the top collaborators of David Oldach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Oldach. David Oldach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mathur, Mohit, Jonathan Barratt, Yusuke Suzuki, et al.. (2022). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers. Kidney International Reports. 7(5). 993–1003. 28 indexed citations

Chen, Marcus Y., Anna McNulty, Ann Avery, et al.. (2019). Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial. The Lancet Infectious Diseases. 19(8). 833–842. 44 indexed citations

Hershberger, Ellie, Susan Sloan, Kristin Narayan, et al.. (2019). Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study. EBioMedicine. 40. 574–582. 63 indexed citations

File, Thomas M., Barbara Rewerska, Anita Das, et al.. (2016). SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia. Clinical Infectious Diseases. 63(8). 1007–1016. 58 indexed citations

Oldach, David, Hristo Metev, Analía Mykietiuk, et al.. (2015). Characterization of Mycoplasma pneumoniae Infection and Outcomes in the SOLITAIRE-Oral, Global Phase 3 Clinical Trial for Solithromycin. Open Forum Infectious Diseases. 2(suppl_1). 2 indexed citations

Manns, M.P., Eric Lawitz, A. I. M. Hoepelman, et al.. (2010). 273 SHORT TERM SAFETY, TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY ACTIVITY OF GS-9450, A SELECTIVE CASPASE INHIBITOR, IN PATIENTS WITH CHRONIC HCV INFECTION. Journal of Hepatology. 52. S114–S115. 10 indexed citations

Lawitz, E.J., Bradley Vince, Nicole Grunenberg, et al.. (2010). 2008 DOSE-RANGING, THREE-DAY MONOTHERAPY STUDY OF THE HCV NS3 PROTEASE INHIBITOR GS-9256. Journal of Hepatology. 52. S466–S467. 10 indexed citations

Morris, J. Glenn, Lynn M. Grattan, Leslie Wilson, et al.. (2006). Occupational Exposure to Pfiesteria Species in Estuarine Waters Is Not a Risk Factor for Illness. Environmental Health Perspectives. 114(7). 1038–1043. 8 indexed citations

Bowers, Holly A., Carmelo R. Tomas, Torstein Tengs, et al.. (2006). RAPHIDOPHYCEAE [CHADEFAUD EX SILVA] SYSTEMATICS AND RAPID IDENTIFICATION: SEQUENCE ANALYSES AND REAL‐TIME PCR ASSAYS¹. Journal of Phycology. 42(6). 1333–1348. 75 indexed citations

10.

Bowers, Holly A., et al.. (2006). Detection of Pfiesteria spp. by PCR in surface sediments collected from Chesapeake Bay tributaries (Maryland). Harmful Algae. 5(4). 342–351. 22 indexed citations

11.

Logvinoff, Carine, Marian Major, David Oldach, et al.. (2004). Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proceedings of the National Academy of Sciences. 101(27). 10149–10154. 332 indexed citations breakdown →

12.

Bowers, Holly A., Torstein Tengs, Howard B. Glasgow, et al.. (2000). Development of Real-Time PCR Assays for Rapid Detection of Pfiesteria piscicida and Related Dinoflagellates. Applied and Environmental Microbiology. 66(11). 4641–4648. 197 indexed citations

13.

Silbergeld, Ellen K., Lynn M. Grattan, David Oldach, & J. Glenn Morris. (2000). Pfiesteria: Harmful Algal Blooms as Indicators of Human: Ecosystem Interactions. Environmental Research. 82(2). 97–105. 18 indexed citations

14.

Oldach, David. (1999). Regarding Pfiesteria. Human Organization. 58(4). 459–460. 5 indexed citations

15.

Golub, J. E., Dirk Haselow, Jeffrey Hageman, et al.. (1998). Pfiesteria in Maryland: preliminary epidemiologic findings.. PubMed. 47(3). 137–43. 14 indexed citations

16.

Auwaerter, Paul G., David Oldach, Linda M. Mundy, et al.. (1996). Hantavirus Serologies in Patients Hospitalized with Community-Acquired Pneumonia. The Journal of Infectious Diseases. 173(1). 237–239. 4 indexed citations

17.

Mundy, Linda M., Paul G. Auwaerter, David Oldach, et al.. (1995). Community-Acquired Pneumonia: Impact of Immune Status. American Journal of Respiratory and Critical Care Medicine. 152(4). 1309–1315. 147 indexed citations

18.

Oldach, David, M. Christine Zink, J M Pyper, et al.. (1995). Induction of protection against Borna disease by inoculation with high-dose-attenuated Borna disease virus. Virology. 206(1). 426–434. 20 indexed citations

19.

Gaydos, C A, Joseph Eiden, David Oldach, et al.. (1994). Diagnosis of Chlamydia pneumoniae Infection in Patients with Community-Acquired Pneumonia by Polymerase Chain Reaction Enzyme Immunoassay. Clinical Infectious Diseases. 19(1). 157–160. 54 indexed citations

20.

Bartlett, Stephen T., David Oldach, & Stephen C. Schimpff. (1989). Organs for transplantation.. BMJ. 299(6713). 1463.1–1464. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact